Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma - Wikidata - awgldk - TriplyDB

Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma

Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma

http://www.wikidata.org/entity/Q39874999

about

Two-stage phase I dose-escalation study of intratumoral reovirus type 3 dearing and palliative radiotherapy in patients with advanced cancers Cell carriage, delivery, and selective replication of an oncolytic virus in tumor in patients Clinical development of reovirus for cancer therapy: An oncolytic virus with immune-mediated antitumor activity Evidence for Oncolytic Virotherapy: Where Have We Got to and Where Are We Going?Potential for Improving Potency and Specificity of Reovirus Oncolysis with Next-Generation Reovirus Variants Modification of mammalian reoviruses for use as oncolytic agents Sickle Cells Abolish Melanoma Tumorigenesis in Hemoglobin SS Knockin Mice and Augment the Tumoricidal Effect of Oncolytic Virus In Vivo A phase I trial of single-agent reolysin in patients with relapsed multiple myeloma Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway.Oncolytic reovirus in canine mast cell tumor.Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites The oncolytic effects of reovirus in canine solid tumor cell lines.Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia.Phase II trial of intravenous administration of Reolysin(®) (Reovirus Serotype-3-dearing Strain) in patients with metastatic melanoma.Oncolytic reovirus synergizes with chemotherapeutic agents to promote cell death in canine mammary gland tumor Reovirus-mediated cytotoxicity and enhancement of innate immune responses against acute myeloid leukemia.Reovirus in cancer therapy: an evidence-based review Tumor infection by oncolytic reovirus primes adaptive antitumor immunity.Oncolytic viruses: a novel form of immunotherapy.Reovirus: a targeted therapeutic--progress and potential.Cytotoxic and immune-mediated killing of human colorectal cancer by reovirus-loaded blood and liver mononuclear cells Reovirus-based therapy for cancer.The case of oncolytic viruses versus the immune system: waiting on the judgment of Solomon.Enhanced cytotoxicity of reovirus and radiotherapy in melanoma cells is mediated through increased viral replication and mitochondrial apoptotic signalling.The evolving role of dendritic cells in cancer therapy.Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity.Evolution of oncolytic viruses: novel strategies for cancer treatment.Armed therapeutic viruses - a disruptive therapy on the horizon of cancer immunotherapy.Activated ras signaling pathways and reovirus oncolysis: an update on the mechanism of preferential reovirus replication in cancer cells.Changing faces in virology: the dutch shift from oncogenic to oncolytic viruses.Targeting Melanoma with Cancer-Killing Viruses.African Swine Fever Virus NP868R Capping Enzyme Promotes Reovirus Rescue during Reverse Genetics by Promoting Reovirus Protein Expression, Virion Assembly, and RNA Incorporation into Infectious Virions.Oncolytic activity of reovirus in HPV positive and negative head and neck squamous cell carcinoma Enhancement of antibody-dependent cell mediated cytotoxicity: a new era in cancer treatment.Reduction of virion-associated σ1 fibers on oncolytic reovirus variants promotes adaptation toward tumorigenic cells.The effects of oncolytic reovirus in canine lymphoma cell lines.Oncolytic viruses: emerging options for the treatment of breast cancer.Measles virus causes immunogenic cell death in human melanoma.Systemic administration of reovirus (Reolysin) inhibits growth of human sarcoma xenografts.

P2860

Q24611483-D832F8B7-7C53-464D-B34D-38B32628F283 Q24617027-73CAFD7A-D57F-4DE3-9308-DC3DB8A98E6F Q26750568-6F393B3B-91C3-4E7D-B3ED-3A9719B42FCA Q26775030-02935696-9240-48FA-BA81-DD1BD1D3D9EC Q26775033-52D1C6F6-7BB1-47A0-B02E-543CB8995B67 Q28264900-ABCA273C-DAB7-41F5-81FE-BC84EAA89068 Q28596621-6080AD4E-9713-4960-AD81-AEE20FC839A9 Q33418048-25CDBB4A-DD0A-4BA0-A681-D473D1ED1E40 Q33551626-CC990456-094C-4B35-8102-C204DE58E759 Q34393001-EE3A6A22-EDD3-45BA-83EA-1BAAA96DE4BC Q35000631-A2C21BAB-3F07-4E0F-B768-2BAE97F0C123 Q35061974-08A6606D-71E6-44EE-9D5E-D26C3ED0DDB1 Q35774578-631BA57B-2CA3-44EB-A805-0A6905C9C2D3 Q35812675-BBFC8786-A593-4CD1-AD89-D8686BD4D584 Q36298608-1AF02E3D-AA89-418A-9C1E-DAC2E164CFF7 Q36390114-93984F48-B0DC-4A3D-824A-49F99DABFEFF Q36574519-878D3007-1389-48AD-B177-6F292768C3F7 Q37031909-E677B2F2-6E1C-4CB9-AEB2-D8CA93D6E270 Q37239555-A23F5E87-5E76-4CD9-85EA-1587F0B4D2AA Q37300008-DFE70960-45E3-4FA3-8143-9F18680626ED Q37360608-98DF1880-9DC7-42AC-BED9-0BCCD40038B4 Q37477574-85511C91-FEB7-462E-80B6-8397A062959E Q37519640-89A1214D-CB1C-47C4-8A9E-5FDAEF4B25CD Q37561072-5A2AD40F-3345-4B25-8665-680E5D190529 Q37565521-EE77F6FA-4CC6-48DD-808B-8CD2AC43D50F Q37687418-B967656A-DD37-4813-B943-3A721A5995AE Q37707676-61B73612-5900-4BC3-96E9-3F1019389A62 Q38159802-EB43742E-1DC6-4B87-A385-2D4C11443629 Q38194135-7CA68679-F701-4263-B29C-2FFA7632BED7 Q38229052-83209F4B-B95C-44C9-AC01-597A5E7DA500 Q38241666-CE602A12-5CE7-4767-AD83-407ECF47B568 Q38676416-8442E3C8-8C00-4262-AB8A-52159EFA0E10 Q38712130-B56B8E87-F2D9-44A7-8FC0-5BFFA9FE1FF2 Q38885144-1E666D4A-3E0C-41FD-A2AC-97DB4A4E5F30 Q38912287-85F000D5-54A3-4273-9326-51C28BC2B98C Q38912745-33A42F5F-0338-497E-9A8C-39648D2ED4A0 Q38947511-8A71034D-8BDE-4181-9682-C1BD409CC66D Q39129326-C768D6D9-2FB9-47E2-AEF2-D41FEBCCF3E2 Q39428453-7EB342FF-DC96-445A-9EB2-C58A17F33670 Q39562583-64C40142-A19E-4DA0-93D4-CB8B916F2340

P2860

Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma

http://www.wikidata.org/entity/Q39874999

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma

@en

Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma.

@nl

type

label

Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma

@en

Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma.

@nl

prefLabel

Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma

@en

Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma.

@nl

P1433

Q39874999-00AC51AA-A346-4706-B346-DB99BF6EDCBC

P1476

Q39874999-9C8EF68B-F25E-4544-861A-22156F1F4981

P2093

Q39874999-036CFE49-EA89-455F-B8B8-E7C2D0CC1962

Q39874999-57F11CAC-B253-484B-B3CA-E4BFE9BB5D18

Q39874999-59F6CD5A-200A-4D08-A07C-F8449B35B808

Q39874999-5F1755A9-DD0A-4411-A566-C60D78A734AD

Q39874999-6A41B7F3-2CA0-44F3-8AF6-A03637C3EC7B

Q39874999-76ECC4BC-E7BB-446D-94F2-AE64F33B0026

Q39874999-7B196CAD-5869-4990-849A-8946176E06F0

Q39874999-98CD3F6B-2C4B-4F24-B506-E22B34F9EC05

Q39874999-B1AA5975-EEA9-4BB9-9FAC-516F8C0CEF47

Q39874999-BB4683B7-C137-492D-B588-8EE2B888DBCA

P2860

Q39874999-01A7EDF2-55B9-4F5A-98B3-8C772337C45F

Q39874999-176420A2-3623-4FD5-99BD-FF6FEF009CCE

Q39874999-1EEB3AA7-C699-41BC-806E-D395C4C369C9

Q39874999-1F69B69B-FFA7-4B50-8FC7-DC0782DA3AA1

Q39874999-22C83D9A-894E-413D-A352-B6AD41F5B044

Q39874999-27793C56-A6E4-400A-A989-CAAD2DF75F38

Q39874999-27DA8CC1-4042-442D-AA9E-F85E2B95CFD6

Q39874999-2D53CD22-597F-4A6A-A364-BF6AD8C38A25

Q39874999-31D20D33-9D86-435D-95BD-DB4D009B9837

Q39874999-34723760-6F01-4D7D-9738-4468F3053BCE

P2888

Q39874999-4B48FFEA-E018-4520-82DF-18A51738D318

P304

Q39874999-3EC26369-29C9-4BBA-8071-AC736731B427

P31

Q39874999-288A4A7C-BFAF-41C2-BA19-F1D2BCEF6666

P356

Q39874999-9B79A678-25E0-40B3-858A-325214D03C8D

P433

Q39874999-83F1F546-2520-4614-BA7D-2F67CB6CF1C5

P478

Q39874999-D7EB3314-C934-48B1-ABB3-3B6CD1D136DB

P50

Q39874999-71DE3F2E-8484-478B-A80C-054C3E84562F

P577

Q39874999-04441A5B-6597-4E65-9964-73D502600B5F

P5875

Q39874999-7AC2F808-A190-4393-99AA-48244994409A

P698

Q39874999-EF00D2AC-F7A9-4080-8EBE-3735E5195DFE

P921

Q39874999-3F3E4571-9326-4172-9625-32D669794C65

Q39874999-FC696B67-4090-480C-8D44-3E31C3CF4B49

P932

Q39874999-5FDF31B6-0C10-4ACD-905A-010C8D1926C9

P356

P1433

P1476

Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma

@en

P2093

A A Melcher

http://www.w3.org/2001/XMLSchema#string

A Rose

http://www.w3.org/2001/XMLSchema#string

C L White

http://www.w3.org/2001/XMLSchema#string

F Errington

http://www.w3.org/2001/XMLSchema#string

H S Pandha

http://www.w3.org/2001/XMLSchema#string

K J Harrington

http://www.w3.org/2001/XMLSchema#string

K R Twigger

http://www.w3.org/2001/XMLSchema#string

L J Ilett

http://www.w3.org/2001/XMLSchema#string

L Steele

http://www.w3.org/2001/XMLSchema#string

M Coffey

http://www.w3.org/2001/XMLSchema#string

P2860

The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

Tumor progression, early diagnosis and prognosis of melanoma.

Apoptosis or necrosis for tumor immunotherapy: what's in a name?

Virion disassembly is required for apoptosis induced by reovirus.

Cytokines and Immune Response in the Tumor Microenvironment.

Reovirus therapy of tumors with activated Ras pathway.

The use of dendritic cells in cancer immunotherapy.

Reovirus-induced apoptosis: A minireview.

Oncogenes in melanoma.

P2888

P304

1257-1270

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/GT.2008.58

http://www.w3.org/2001/XMLSchema#string

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5452152

http://www.w3.org/2001/XMLSchema#string

P698

18401435

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

4821075

http://www.w3.org/2001/XMLSchema#string